The webinar will introduce the advantages of bispecific antibodies (bsAbs), their mechanism of action (MOA), and the development history of bsAb platform.

06-18-2024 Dr. Wang Sai, Senior Scientist (Protein), GenScript

Learn More

In vitro transcribed (IVT) mRNA has emerged as a powerful therapeutic and preventive modality that can offer solutions for infectious diseases, cancer, monogenic disorders, and more.

05-22-2024 Dr. Yerim Kwon, Field Application Scientist, APAC region

Learn More

Multi-transmembrane proteins, especially G-protein coupled receptors (GPCRs), are extremely difficult to develop antibodies against due to their low expression levels, insolubility in vitro, unstable purification and difficulty in maintaining their native

05-10-2024 Dr. Tingting Xiao, Antibody Senior Scientist, GenScript

Learn More

FREE WEBINAR! CRISPR screens decode human T cell function

04-17-2024 Ralf Schmidt, MD Department of Laboratory Medicine Medical University of Vienna

Learn More

Unlock the potential of protein discovery and target identification with the combined power of Allozymes' microfluidics platform and GenScript's gene synthesis expertise. This webinar delves into the exciting partnership between these two innovators, show

03-27-2024 Dr. Charlie Zou (Head of Project Management Dept.of Molecular Biology, GenScript) / Dr. Akbar Vahidi (CTO, Co-founder)

Learn More

Discover a groundbreaking webinar exploring the developments in cancer immunotherapy targeting CC chemokine receptor 9 (CCR9), a potential breakthrough for T-cell acute lymphoblastic leukemia (T-ALL). 

03-06-2024 Dr. Paul Maciocia, Clinical Scientist and Honorary Consultant Haematologist, Cancer Institute, University College London

Learn More